Because SIRT5 is essential in preserving BAT/WAT balance, and since BAT is involved in glucose homeostasis, SIRT5 may be a target for the therapy of certain metabolic diseases such as obesity and type 2 diabetes [93]. The gene discussed is SIRT5; the disease is Other metabolic disease.